Masimo Corporation (NASDAQ:MASI) Director Sanford Fitch sold 11,000 shares of the company’s stock in a transaction that occurred on Thursday, August 17th. The stock was sold at an average price of $87.25, for a total value of $959,750.00. Following the sale, the director now directly owns 72,249 shares in the company, valued at $6,303,725.25. The sale was disclosed in a filing with the SEC, which is available through this link.

Sanford Fitch also recently made the following trade(s):

  • On Thursday, July 13th, Sanford Fitch sold 6,000 shares of Masimo Corporation stock. The stock was sold at an average price of $91.89, for a total value of $551,340.00.
  • On Thursday, June 29th, Sanford Fitch sold 14,000 shares of Masimo Corporation stock. The stock was sold at an average price of $92.06, for a total value of $1,288,840.00.

Masimo Corporation (MASI) traded up 0.71% during mid-day trading on Monday, reaching $86.39. The company had a trading volume of 302,079 shares. Masimo Corporation has a 52 week low of $53.78 and a 52 week high of $104.71. The stock has a market capitalization of $4.49 billion, a price-to-earnings ratio of 14.16 and a beta of 0.80. The stock has a 50 day moving average of $91.26 and a 200 day moving average of $90.35.

Masimo Corporation (NASDAQ:MASI) last announced its quarterly earnings data on Wednesday, August 2nd. The medical equipment provider reported $0.83 EPS for the quarter, topping the Zacks’ consensus estimate of $0.71 by $0.12. Masimo Corporation had a return on equity of 23.45% and a net margin of 45.90%. The firm had revenue of $192.90 million for the quarter, compared to the consensus estimate of $189.03 million. During the same quarter last year, the business posted $0.57 earnings per share. The firm’s revenue was up 11.8% compared to the same quarter last year. Analysts anticipate that Masimo Corporation will post $2.80 earnings per share for the current year.

TRADEMARK VIOLATION NOTICE: “Sanford Fitch Sells 11,000 Shares of Masimo Corporation (MASI) Stock” was first published by American Banking News and is the property of of American Banking News. If you are viewing this piece of content on another website, it was illegally stolen and reposted in violation of international copyright & trademark laws. The legal version of this piece of content can be accessed at https://www.americanbankingnews.com/2017/08/21/sanford-fitch-sells-11000-shares-of-masimo-corporation-masi-stock.html.

A number of institutional investors have recently made changes to their positions in MASI. Fortaleza Asset Management Inc. bought a new position in shares of Masimo Corporation during the second quarter worth approximately $106,000. Neuburgh Advisers LLC increased its position in shares of Masimo Corporation by 6.4% in the first quarter. Neuburgh Advisers LLC now owns 1,328 shares of the medical equipment provider’s stock worth $124,000 after buying an additional 80 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its position in shares of Masimo Corporation by 32.2% in the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,782 shares of the medical equipment provider’s stock worth $166,000 after buying an additional 434 shares during the last quarter. Dubuque Bank & Trust Co. bought a new position in shares of Masimo Corporation during the first quarter worth approximately $169,000. Finally, Glen Harbor Capital Management LLC increased its position in shares of Masimo Corporation by 6.4% in the first quarter. Glen Harbor Capital Management LLC now owns 1,826 shares of the medical equipment provider’s stock worth $170,000 after buying an additional 110 shares during the last quarter. Hedge funds and other institutional investors own 84.14% of the company’s stock.

MASI has been the topic of several recent research reports. BidaskClub cut Masimo Corporation from a “hold” rating to a “sell” rating in a report on Wednesday, August 9th. Zacks Investment Research raised Masimo Corporation from a “sell” rating to a “hold” rating in a report on Tuesday, July 11th. Stifel Nicolaus reaffirmed a “buy” rating and set a $108.00 price objective (up from $105.00) on shares of Masimo Corporation in a report on Thursday, August 3rd. Wedbush reaffirmed an “outperform” rating and set a $112.00 price objective on shares of Masimo Corporation in a report on Monday, May 22nd. Finally, BTIG Research raised Masimo Corporation from a “neutral” rating to a “buy” rating and set a $100.00 price objective on the stock in a report on Monday, August 14th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and four have issued a buy rating to the stock. The stock has an average rating of “Hold” and an average target price of $95.00.

Masimo Corporation Company Profile

Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.

Insider Buying and Selling by Quarter for Masimo Corporation (NASDAQ:MASI)

Receive News & Ratings for Masimo Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corporation and related companies with MarketBeat.com's FREE daily email newsletter.